Market Access Insights
Access the relevant market access data and insights you need on health plans, policy restrictions, PBMs, providers, and more
Report
May 20, 2011
Formulary Advantages in Hepatitis C: Despite the near certainty of emerging oral protease inhibitors, pharmacy directors remain unsure of the…
According to the American Liver Foundation, 4 million Americans, or 1.8% of the population, are or have been infected with the hepatitis C virus. Approximately 70% of infected persons will develop a c…
